Latest Breaking News On - Amneal pharmaceutical - Page 8 : comparemela.com

California is joining with a New Jersey company to buy a generic opioid overdose reversal drug

California is partnering with a New Jersey-based pharmaceutical company to purchase a generic version of Narcan, the most well-known version of naloxone that can save a person's life during an opioid overdose.

United statesGavin newsomAmneal pharmaceuticalsDrug administrationNew jersey basedNaloxone distributionNaloxone distribution projectAmneal pharmaceutical

California is joining with a New Jersey company to make a generic opioid overdose reversal drug

California is partnering with a New Jersey-based pharmaceutical company to purchase a generic version of Narcan. It s the most well-known version of naloxone that can save a person s life during

United statesMark ghalyElizabeth landsbergAnthony wrightGavin newsomCalifornia healthDrug administrationHealth access californiaHuman services agencyAmneal pharmaceuticalsCalifornia department of healthcare accessCalifornia department of public healthNew jersey based amneal pharmaceuticalsNaloxone distributionCalifornia departmentHealthcare access

California is joining with a New Jersey company to make a generic opioid overdose reversal drug

California is partnering with a New Jersey-based pharmaceutical company to purchase a generic version of Narcan

United statesMark ghalyAnthony wrightGavin newsomElizabeth landsbergCalifornia department of healthcare accessCalifornia healthCalifornia department of public healthHealth access californiaHuman services agencyAssociated pressAmneal pharmaceuticalsDrug administrationNew jersey based amneal pharmaceuticalsNaloxone distributionCalifornia department

FTC weighs in on Teva s inhaler litigation against Amneal amid far-reaching patent crackdown

FTC weighs in on Teva s inhaler litigation against Amneal amid far-reaching patent crackdown
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

New jerseyUnited statesTeva amnealBoehringer ingelheimUs federal trade commissionTrade commissionAmneal pharmaceuticalOrange bookFierce pharmaImpax laboratories

Insiders the biggest winners as Amneal Pharmaceuticals, Inc s (NASDAQ:AMRX) market cap rises to US$1 8b

Key Insights Amneal Pharmaceuticals' significant insider ownership suggests inherent interests in company's expansion.

Tushar patelChirag patelAmneal pharmaceuticalsAmneal pharmaceuticals incInstitutional ownership tell us about amneal pharmaceuticalsCompany ownershipAmneal pharmaceuticalPrivate companiesNsider ownershipShares outstanding